These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 8605566)

  • 1. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
    Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megakaryocyte features and bcr/abl translocation in chronic myeloid leukemia following imatinib mesylate (STI571) therapy--a fluorescence in-situ hybridization study.
    Thiele J; Kvasnicka HM; Varus E; Ollig E; Schmitt-Graeff A; Staib P; Griesshammer M
    Leuk Lymphoma; 2004 Aug; 45(8):1627-31. PubMed ID: 15370216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in-situ hybridization (FISH) reveals that in chronic myelogenous leukaemia (CML) following interferon-alpha therapy, normalization of megakaryocyte size is associated with the loss of bcr/abl translocation.
    Thiele J; Schmitz B; Gross H; Kvasnicka HM; Niederle N; Leder LD; Fischer R
    Histopathology; 1997 Sep; 31(3):215-21. PubMed ID: 9354890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells.
    Yanagi M; Shinjo K; Takeshita A; Tobita T; Yano K; Kobayashi M; Terasaki H; Naoe T; Ohnishi K; Ohno R
    Leukemia; 1999 Apr; 13(4):542-52. PubMed ID: 10214860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases.
    Aye le L; Loghavi S; Young KH; Siddiqi I; Yin CC; Routbort MJ; Liang M; Eilerman K; Medeiros LJ; Brynes RK; Bueso-Ramos C
    Ann Diagn Pathol; 2016 Apr; 21():53-8. PubMed ID: 27040932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocation.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Wilkens L; Link H; Ganser A; Georgii A
    Leuk Lymphoma; 1996 Jul; 22(3-4):287-94. PubMed ID: 8819078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of the BCR-ABL fusion: Comparative analysis of six commercially available FISH fusion probes].
    Knas T; Buck M; Stegelmann F; Möller P; Barth TF
    Pathologe; 2015 Jul; 36(4):372-84. PubMed ID: 26175197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic myeloid leukemia onset with marked thrombocythemia].
    Shen Q; Zhou JW; Zhu GR; Yang YY; Qiu HR; Zhu GR; Xia W; Jiang PJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):247-51. PubMed ID: 16638190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of interphase fluorescence in situ hybridization for BCR/ABL on peripheral blood smears for monitoring of CML patients: a comparison with bone marrow findings.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Clin Lab Haematol; 2002 Dec; 24(6):361-7. PubMed ID: 12452817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term culturing influences the number of bcr/abl-fused cells detected by fluorescence in situ hybridisation in bone marrow aspirates of CML patients.
    Wilkens L; Varga S; Werner M; Nolte M; v Wasielewski R; Georgii A
    Pathobiology; 1999; 67(4):163-8. PubMed ID: 10738176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of fluorescence in situ hybridization for detecting the bcr/abl gene fusion in interphase cells of routine bone marrow specimens.
    Werner M; Ewig M; Nasarek A; Wilkens L; von Wasielewski R; Tchinda J; Nolte M
    Diagn Mol Pathol; 1997 Oct; 6(5):282-7. PubMed ID: 9458387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis and identification of variant Ph chromosome translocation in patients with chronic myelogenous leukemia by conventional cytogenetics and fluorescence in situ hybridization].
    Liu XP; Liu SH; Li CW; Bo LJ; Qin S; Dai Y; Qian LS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):298-303. PubMed ID: 15228654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring of the therapeutic response of interferon to chronic myeloid leukemia by duel-color fluorescence in situ hybridization].
    Song YQ; Li W; Kong LH; Wang GJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):38-40. PubMed ID: 12667287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in laboratory medicine in chronic myeloid leukemia].
    Miura A
    Rinsho Byori; 1998 Dec; 46(12):1226-31. PubMed ID: 9916508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.
    Tosi S; Cabot G; Giudici G; Attuati V; Morandi P; Rambaldi A; Döhner H; Biondi A
    Cancer Genet Cytogenet; 1996 Jul; 89(2):153-6. PubMed ID: 8697423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
    Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
    Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.